A|B|C|D|E|F|G|H|I|J|K|L|M|N|O|P|Q|R|S|T|U|V|W|X|Y|Z|ALL

  检 索： 期刊名称 ISSN         高级检索

期刊名称：ACS INFECTIOUS DISEASES ISSN： 2373-8227 出版频率： Monthly 出版社： AMER CHEMICAL SOC, 1155 16TH ST, NW, WASHINGTON, USA, DC, 20036   出版社网址： http://pubs.acs.org/ 期刊网址： http://pubs.acs.org/journal/aidcbc 影响因子： 5.084 主题范畴： CHEMISTRY, MEDICINAL;    INFECTIOUS DISEASES 变更情况： Newly Added by 2016 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal About the Journal ACS Infectious Diseases is the first journal to highlight chemistry and its role in the multidisciplinary and collaborative field of infectious disease research. The scope of the journal encompasses all aspects of chemistry relating to infectious diseases research including research on pathogens, host-pathogen interactions, therapeutics, diagnostics, vaccines, drug-delivery systems, and other biomedical technology development pertaining to infectious diseases. With editors well-versed in both chemistry and the biology of infectious diseases, the journal aims to bridge the gap between these two disciplines. ACS Infectious Diseases welcomes submission of articles with a balance of chemistry and biology, and encourages discussions centered on specific pathogen- and disease-related issues. Journal Scope Topics covered by the journal include but are not limited to the following: Pathogens and Host-Pathogen Interactions Use of structural biology, chemical biology, glycobiology, physical chemistry, nucleic acid chemistry, and biochemistry to elucidate molecular mechanisms of pathogenesis Development of tools to dissect mechanisms of pathogenesis Therapeutics Use of target-, phenotypic-, or computational-based approaches for discovery and development of new agents to treat infectious diseases, with an emphasis on establishing mechanism of action, understanding binding mode and inhibitory mechanism, and/or discussing pathogen-specific challenges to drug development Development of new technologies to facilitate characterization, validation, and prioritization of potential drug targets or to assess the physicochemical bases for cellular penetration of anti-infectives Mechanistic investigations of antimicrobial resistance Vaccines Discovery and development of synthetic vaccines and small molecule vaccine adjuvants Structural, physical, or computational investigations of epitope binding Diagnostics Development of novel and improved diagnostics using physical, surface, analytical, and nano chemistry techniques Use of structural biology, molecular biology, and chemical biology to investigate diagnostics targets Drug Delivery Systems Use of novel materials and technologies, such as nanotechnologies, for delivery of antimicrobial agents Instructions to Authors Overview Manuscripts and supporting information must be submitted through the ACS Paragon Plus Environment. Please review the Author Guidelines [PDF] before beginning your manuscript submission. This journal does not require the use of a manuscript template and does not provide journal-specific templates. For any type of submission, the author should prepare the manuscript as a double-spaced electronic file. Important Note: ACS Infectious Diseases requests that authors provide a short (~150 word) lay-summary (at the level of an undergraduate in biochemistry) describing the significance of the study for a broad audience. This lay summary should be included in the cover letter. It will be used to promote your research article through press communications. Table of Contents (TOC) Art and Other Specifications TOC art is a vital part of your manuscript submission; without it the publication of your manuscript will be delayed. TOC art should reflect the content and is a visual abstract designed to inform readers of the content and invite them to take a closer look. A guide to TOC art has been produced and is available here [PDF]. See also How to Submit a Manuscript for complete information on acceptable software, preparing and submitting manuscripts using TeX/LaTeX, correct preparation of graphics, etc. Manuscript Transfer Service Sometimes an ACS journal editor finds that a submitted manuscript is more suitable for a different ACS journal. The Manuscript Transfer Service allows the author(s) to transfer the manuscript and submission details to another ACS journal without restarting the entire submission process. See complete description. Instructions to Authors aidcbc_authguide.pdf Editorial Board Editor-in-Chief Courtney C. Aldrich Department of Medicinal Chemistry College of Pharmacy, University of Minnesota Editor's Office: (612) 625-7956 E-mail: eic@id.acs.org Editorial Advisory Board [PDF] Acquisitions Editor Janice E. Silverman E-mail: j_silverman@acs.org Managing Editor Lorraine Clark Phone: (202) 872-6984 E-mail: l_clark@acs.org Associate Editors John P. Pezacki University of Ottawa E-mail: pezacki-office@id.acs.org Pei-Yong Shi University of Texas Medical Branch E-mail: shi‐office@id.acs.org Peter Tonge Stony Brook University E-mail: tonge-office@id.acs.org   Elizabeth Winzeler University of California, San Diego Email: winzeler-office@id.acs.org Gerard Wright McMaster University Email: wright-office@id.acs.org Editorial Advisory Board Michelle R. Arkin University of California, San Francisco Clifton E. Barry, III NIH/NIAID Helen Blackwell University of Wisconsin, Madison Heike Brötz-Oesterhelt Microbial Bioactive Compounds Eric D. Brown McMaster University Michael D. Burkart University of California, San Diego Kelly Chibale University of Cape Town Luiz Pedro Sorio de Carvalho The Francis Crick Institute Thierry Tidiane Diagana Novartis Institute for Tropical Diseases David A. Fidock Columbia University Medical Center Colin Fishwick University of Leeds Caren L. Freel Meyers Johns Hopkins University Sylvie Garneau-Tsodikova University of Kentucky Ian Gilbert University of Dundee Stanislav Gobec University of Ljubljana Jayanta Haldar Jawaharlal Nehru Centre for Advanced Scientific Research Daria J. Hazuda Merck and Company Anna Hirsch University of Groningen Deb Hung Harvard Medical School Satoshi Ichikawa Hokkaido University Audrey John Washington University School of Medicine Thomas Keller Experimental Therapeutics Centre Kimberly Kline Nanyang Technological University Damian Krysan University of Rochester Medical Center   Richard E. Lee St. Jude Children's Research Hospital Jennifer A. Leeds Novartis Institutes for Biomedical Research Dennis D. Liotta Emory University Zhenkun Ma TenNor Therapeutics Limited Nicholas A. Meanwell Bristol-Myers Squibb Christian C. Melander North Carolina State University Valerie Mizrahi University of Cape Town Shahriar Mobashery University of Notre Dame Johan Neyts University of Leuven Terry D. Roemer Merck and Company Polly Roy London School of Hygiene & Tropical Medicine Celia A. Schiffer University of Massachusetts Medical School Megan Shaw Mount Sinai Hospital Hong C. Shen Roche Innovation Center Shangahi Chunquan Sheng Second Military Medical University Lynn Silver LL Silver Consulting LLC Erick Strauss Stellenbosch University Ruben Tommasi Entasis Therapeutics John C. Vederas University of Alberta Jonathan L. Vennerstrom University of Nebraska Medical Center Zhengqiang Wang University of Minnesota Priscilla Yang Harvard Medical School Fumiaki Yokokawa Novartis Institute for Tropical Diseases